Loading...
Please wait while we fetch the latest data
Please wait while we fetch the latest data
Anthem Biosciences, established in 2006, is an innovation-driven Contract Research, Development, and Manufacturing Organisation (CRDMO) that offers in...
Current GMP
+₹570
Last Updated
2026-03-27T09:30:14.033Z
₹null - ₹null
TBA
TBA
NSE/BSE
Registrar: TBA
Anthem Biosciences, established in 2006, is an innovation-driven Contract Research, Development, and Manufacturing Organisation (CRDMO) that offers integrated services in drug discovery, development, and manufacturing. The company specialises in fermentation-based APIs, including probiotics, enzymes, peptides, and biosimilars, catering to both biotech startups and large pharma worldwide. With 196 active projects, including 170 discovery projects, Anthem’s R&D spans RNAi, ADCs, and peptides. The company’s manufacturing facilities, including one under construction, support a broad portfolio of custom synthesis and fermentation capabilities. Known for green chemistry and cutting-edge technologies, Anthem is a leader in delivering sustainable, high-quality solutions across regulated markets.
Open Date
2025-07-14
Close Date
2025-07-16
Basis of Allotment
TBA
Refund Initiation
TBA
Credit to Demat
TBA
Listing Date
2025-07-21
Download our app to get alerts for GMP changes, subscription, and allotment
Download App